Bionano Genomics, Inc. — Director's Dealing 2020

Sep 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Bionano Genomics, Inc (BNGO)
CIK: 0001411690
Period of Report: 2020-09-01

Reporting Person: Stewart Christopher P. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-09-01	Stock Option (Right to Buy)	$0.56	A	350000	Acquired	2030-09-01	Common Stock (350000)	Direct
2020-09-01	Stock Option (Right to Buy)	$0.56	A	225000	Acquired	2030-09-01	Common Stock (225000)	Direct

Footnotes

F1: 25% of the shares subject to the stock option vest and become exercisable on September 1, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such applicable vesting date and the terms of the Issuer's 2020 Inducement Plan, subject to acceleration of vesting as provided for in that certain Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.

F2: The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.